Clinical features of Pittsburgh compound-B-negative dementia

Dementia and Geriatric Cognitive Disorders

Volumn 34, Issue 2, 2012, Pages 112-120

  Takeuchi, Jun ^a   Shimada, Hiroyuki ^a   Ataka, Suzuka ^a   Kawabe, Joji ^b   Mori, Hiroshi ^c   Mizuno, Kei ^d   Wada, Yasuhiro ^d   Shiomi, Susumu ^b   Watanabe, Yasuyoshi ^a,d   Miki, Takami ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d RIKEN   (Japan)

Author keywords

123I MIBG myocardial scintigraphy; Alzheimer's disease; Biomarkers; Cerebrospinal fluid biomarkers; FDG PET; MRI; Pittsburgh compound B; Tauopathy; Voxel based morphometry

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; APOLIPOPROTEIN E; BIOLOGICAL MARKER; FLUORODEOXYGLUCOSE; PITTSBURGH COMPOUND B;

ADULT; AGED; ALZHEIMER DISEASE; ARGYROPHILIA; ARGYROPHILIC GRAIN DISEASE; ARTICLE; BRAIN ATROPHY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC ACCURACY; FEMALE; FRONTOTEMPORAL DEMENTIA; HIPPOCAMPUS; HUMAN; LEWY BODY; MALE; MEDIASTINUM; MINI MENTAL STATE EXAMINATION; MYOCARDIAL PERFUSION IMAGING; NEUROFIBRILLARY TANGLE PREDOMINANT DEMENTIA; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; POSITRON EMISSION TOMOGRAPHY; PRECUNEUS; PRIORITY JOURNAL; TAUOPATHY; VOXEL BASED MORPHOMETRY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANILINE COMPOUNDS; CASE-CONTROL STUDIES; DEMENTIA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IODINE RADIOISOTOPES; LEWY BODY DISEASE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TAU PROTEINS; THIAZOLES;

EID: 84865597014     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000341577     Document Type: Article

References (23)

1. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang GF, Estrada S, Ausen B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Langstrom B: Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B. Ann Neurol 2004;55: 306-319.
2. Shimada H, Ataka S, Takeuchi J, Mori H, Wada Y, Watanabe Y, Miki T: Pittsburgh compound B-negative dementia - a possibility of misdiagnosis of patients with non- Alzheimer disease-type dementia as having AD. J Geriatr Psychiatry Neurol 2011;24: 123-126.
3. Cairns NJ, Ikonomovic MD, Benzinger T, Storandt M, Fagan AM, Shah AR, Reinwald LT, Carter D, Felton A, Holtzman DM, Mintun MA, Klunk WE, Morris JC: Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report. Arch Neurol 2009;66:1557-1562.
4. Rosen RF, Ciliax BJ, Wingo TS, Gearing M, Dooyema J, Lah JJ, Ghiso JA, LeVine H, Walker LC: Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer's disease. Acta Neuropathol 2009; 119:221-233.
5. Shimada H, Ataka S, Tomiyama T, Takechi H, Mori H, Miki T: Clinical course of patients with familial early-onset Alzheimer's disease potentially lacking senile plaques bearing the E693Delta mutation in amyloid precursor protein. Dement Geriatr Cogn Disord 2011;32:45-54.
6. Kosaka K: Diffuse Lewy body disease. Neuropathology 2000;20(suppl):S73- S78.
7. Yoshita M, Taki J, Yokoyama K, Noguchi- Shinohara M, Matsumoto Y, Nakajima K, Yamada M: Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD. Neurology 2006;66:1850-1854.
8. Adachi T, Saito Y, Hatsuta H, Funabe S, Tokumaru AM, Ishii K, Arai T, Sawabe M, Kanemaru K, Miyashita A, Kuwano R, Nakashima K, Murayama S: Neuropathological asymmetry in argyrophilic grain disease. J Neuropathol Exp Neurol 2010;69:737-744.
9. Ashburner J, Friston KJ: Voxel-based morphometry - the methods. Neuroimage 2000; 11:805-821.
10. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
11. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M: Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65: 1863-1872.
12. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE: A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections offluorine-18-FDG PET. J Nucl Med 1995;36: 1238-1248.
13. Gomperts SN, Rentz DM, Moran E, Becker JA, Locascio JJ, Klunk WE, Mathis CA, Elmaleh DR, Shoup T, Fischman AJ, Hyman BT, Growdon JH, Johnson KA: Imaging amyloid deposition in Lewy body diseases. Neurology 2008;71:903-910.
14. Foster ER, Campbell MC, Burack MA, Hartlein J, Flores HP, Cairns NJ, Hershey T, Perlmutter JS: Amyloid imaging of Lewy body-associated disorders. Mov Disord 2010; 25:2516-2523.
15. Treglia G, Cason E: Diagnostic performance of myocardial innervation imaging using MIBG scintigraphy in differential diagnosis between dementia with Lewy bodies and other dementias: a systematic review and a meta-analysis. J Neuroimaging 2012;22: 111-117.
16. Hanyu H, Shimizu S, Hirao K, Sakurai H, Iwamoto T, Chikamori T, Hida S, Yamashina A, Koizumi K, Abe K: The role of 123I-metaiodobenzylguanidine myocardial scintigraphy in the diagnosis of Lewy body disease in patients with dementia in a memory clinic. Dement Geriatr Cogn Disord 2006;22: 379-384.
17. Yamada M: Senile dementia of the neurofibrillary tangle type (tangle-only dementia): neuropathological criteria and clinical guidelines for diagnosis. Neuropathology 2003; 23:311-317.
18. Saito Y, Murayama S: Neuropathology of mild cognitive impairment. Neuropathology 2007;27:578-584.
19. Rombouts SA, Barkhof F, Witter MP, Scheltens P: Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease. Neurosci Lett 2000;285:231-233.
20. Greicius MD, Srivastava G, Reiss AL, Menon V: Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci USA 2004;101:4637-4642.
21. Sheline YI, Raichle ME, Snyder AZ, Morris JC, Head D, Wang S, Mintun MA: Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly. Biol Psychiatry 2010;67:584-587.
22. Karas G, Scheltens P, Rombouts S, Schijndel R, Klein M, Jones B, Flier W, Vrenken H, Barkhof F: Precuneus atrophy in early-onset Alzheimer's disease: a morphometric structural MRI study. Neuroradiology 2007;49: 967-976.
23. Shiino A, Watanabe T, Kitagawa T, Kotani E, Takahashi J, Morikawa S, Akiguchi I: Different atrophic patterns in early- and lateonset Alzheimer's disease and evaluation of clinical utility of a method of regional zscore analysis using voxel-based morphometry. Dement Geriatr Cogn Disord 2008;26: 175-186.